Conmed Corp [CNMD] stock prices are down -0.30% to $50.14 at the moment. An important factor to consider is whether the stock is rising or falling in short-term value. The CNMD shares have lost -0.10% over the last week, with a monthly amount drifted -3.73%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Conmed Corp [NYSE: CNMD] stock has seen the most recent analyst activity on June 12, 2025, when Needham downgraded its rating to a Hold. Previously, Stifel downgraded its rating to Hold on April 28, 2025, and kept the price target unchanged to $55. On February 06, 2025, downgrade downgraded it’s rating to Neutral and revised its price target to $70 on the stock. Needham reiterated its Buy rating and increased its price target to $129 on February 01, 2024. CL King initiated its recommendation with a Buy and recommended $140 as its price target on May 22, 2023. KeyBanc Capital Markets upgraded its rating to Overweight for this stock on March 27, 2023, but kept the price target unchanged to $124. In a note dated March 21, 2023, Wells Fargo initiated an Equal Weight rating and provided a target price of $96 on this stock.
The stock price of Conmed Corp [CNMD] has been fluctuating between $46.00 and $78.19 over the past year. Currently, Wall Street analysts expect the stock to reach $61 within the next 12 months. Conmed Corp [NYSE: CNMD] shares were valued at $50.14 at the most recent close of the market. An investor can expect a potential return of 21.66% based on the average CNMD price forecast.
Analyzing the CNMD fundamentals
The Conmed Corp [NYSE:CNMD] reported sales of 1.32B for trailing twelve months, representing a surge of 3.51%. Gross Profit Margin for this corporation currently stands at 0.55% with Operating Profit Margin at 0.13%, Pretax Profit Margin comes in at 0.11%, and Net Profit Margin reading is 0.09%. To continue investigating profitability, this company’s Return on Assets is posted at 0.05, Equity is 0.13 and Total Capital is 0.09. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.91.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 49.55 points at the first support level, and at 48.97 for the second support level. However, for the 1st resistance point, the stock is sitting at 50.98, and for the 2nd resistance point, it is at 51.82.
Ratios To Look Out For
It’s worth pointing out that Conmed Corp [NYSE:CNMD]’s Current Ratio is 2.26. On the other hand, the Quick Ratio is 1.00, and the Cash Ratio is 0.13. Considering the valuation of this stock, the price to sales ratio is 1.17, the price to book ratio is 1.59 and price to earnings (TTM) ratio is 14.16.
Transactions by insiders
Recent insider trading involved Farkas Charles, Director, that happened on May 05 ’25 when 4000.0 shares were sold. Director, Farkas Charles completed a deal on May 05 ’25 to buy 4000.0 shares. Meanwhile, Former Officer Hartman Curt R bought 2905.0 shares on Feb 14 ’25.
